மார்டின் ஷில்லர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Heligenics & The Jackson Laboratory Announce New Collaboration on ERBB2 Breast Cancer Gene Includes licensing of custom Heligenics Gene Mutation/Function ERBB2 library for the JAX Clinical Knowledgebase News provided by Share this article Share this article LAS VEGAS, May 11, 2021 /PRNewswire/ Heligenics, Inc. today announced a new collaboration with The Jackson Laboratory (JAX). This joint project will make available the functional output of Variants of Unknown Significance (VUS) throughout key portion of the ERBB2 gene through the JAX Clinical Knowledgebase (CKB), a digital resource that connects clinicians and researchers around the globe in order to interpret complex cancer genomic profiles.

University of nevadaUnited statesJens rueterHeligenic gigaassayMartinr schillerMartin schillerLas vegasSara pattersonMaine cancer genomics initiativeHeligenics incorporatedHeligenics incPrnewswire heligenics incNevada institute of personalized medicineJackson laboratoryUnknown significanceCancer genomics initiative